[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content

Advertisement

Springer Nature Link
Log in

Is mean platelet volume a simple marker of non-alcoholic fatty liver disease?

  • Original Article
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Due to the increasing prevalence of non-alcoholic fatty liver disease (NAFLD), there was a need to establish non-invasive tests for its detection. Mean platelet volume (MPV) is an inexpensive, practical and easily accessible marker of inflammation in many disorders. Our study was aimed at investigating the relationship between MPV and both NAFLD and liver histology.

Methods

Total 290 patients with biopsy-proven NAFLD (n = 124) and 108 control patients were included in the study. To exclude the effect of other diseases on MPV, we included 156 patient controls in our study. Those whohave liver-related diseases and those who use drugs that may cause fatty liver were not included in the study. Liver biopsy was performed for those whose alanine aminotransferase level persisted for >6 months above the upper limits.

Results/Conclusion

We found that MPV was significantly higher in the NAFLD group compared with the control group, and MPV had an independent predictive value for the development of NAFLD. We determined that the number of platelets was significantly lower in the NAFLD group compared with that in the control group. We compared MPV values histologically with both stage and grade in all patients with biopsy-proven NAFLD and found that MPV had a significant positive correlation with stage. We observed a positive correlation between MPV and non-alcoholic steatohepatitis grade, but this was not statistically significant. MPV can be useful because it is simple, easy to measure, cost-effective, and routinely tested in daily practice. MPV can be used as a simple marker of NAFLD and an indicator of fibrosis-stage in NAFLD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. De Alwis NM, Day CP. Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol. 2008;48 Suppl 1:S104–12.

  2. Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ. Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol. 2008;14:2474–86.

  3. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–57.

  4. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402

  5. Ratziu V, Charlotte F, Heurtier A, et al. LIDO Study Group. Sampling variability of liver biopsy in non-alcoholic fatty liver disease. Gastroenterology. 2005;128:1898–906.

  6. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002;16:663–78.

    Article  CAS  PubMed  Google Scholar 

  7. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human non-alcoholic steatohepatitis. Am J Gastroenterol. 2008;103:1372–9.

  8. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res. 2013;112:1506–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8:148–56.

    Article  CAS  PubMed  Google Scholar 

  10. Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets. 2002;13:301–6.

  11. Eminler AT, Uslan MI, Ayyildiz T, et al. Mean platelet volume is an important predictor of hepatitis C but not hepatitis B liver damage. J Res Med Sci. 2015;20:865–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Bancroft AJ, Abel EW, Mclaren M, Belch JJ. Mean platelet volume is a useful parameter: A reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2000;11:379–87.

  13. Celikbilek M, Gürsoy S, Deniz K, et al. Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease. Platelets. 2013;24:194–9.

    Article  CAS  PubMed  Google Scholar 

  14. Alkhouri N, Kistangari G, Campbell C, Lopez R, Zein NN, Feldstein AE. Mean platelet volume as a marker of increased cardiovascular risk in patients with nonalcoholic steatohepatitis. Hepatology. 2012;55:331.

  15. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708–15.

  16. Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.

  17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.

  18. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Non-alcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.

  19. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. N Engl J Med. 2010;363:1341–50.

  20. Gasparyan Ay, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des. 2011;17:47–58.

  21. Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab. 2008;19:371–9.

    Article  CAS  PubMed  Google Scholar 

  22. Stefan N, Kantartzis K, Häring HU. Causes and metabolic consequences of Fatty liver. Endocr Rev. 2008;29:939–60.

    Article  CAS  PubMed  Google Scholar 

  23. Papanas N, Symeonidis G, Maltezos E, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets. 2004;15:475–8.

    Article  CAS  PubMed  Google Scholar 

  24. Varol E, Akcay S, Ozaydin M, et al. Mean platelet volume is associated with insulin resistance in non-obese, non-diabetic patients with coronary artery disease. J Cardiol. 2010;56:154–8.

    Article  PubMed  Google Scholar 

  25. Kilciler G, Genc H, Tapan S, et al. Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Ups J Med Sci. 2010;115:253–9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ozhan H, Aydin M, Yazici M, et al. Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets. 2010;21:29–32.

    Article  CAS  PubMed  Google Scholar 

  27. Shin W-Y, Jung D-H, Shim J-Y, Lee H-R. The association between non-alcoholic hepatic steatosis and mean platelet volume in an obese Korean population. Platelets. 2011;22:442–6.

    Article  CAS  PubMed  Google Scholar 

  28. Kocabay G, Karabay CY, Kalayci A, Colak Y. Mean platelet volume in patients with non-alcoholic fatty liver disease: is mean platelet volume ready as a surrogate marker? Clin Chem Lab Med. 2014;52:e249–52.

    Article  CAS  PubMed  Google Scholar 

  29. Milovanovic Alempijevic T, Stojkovic Lalosevic M, Dumic I, et al. Diagnostic accuracy of platelet count and platelet indices in noninvasive assessment of fibrosis in non-alcoholic fatty liver disease patients. Can J Gastroenterol Hepatol. 2017;2017:6070135.

  30. Abdel-Razik A, Mousa N, Shabana W, et al. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of non-alcoholic steatohepatitis in NAFLD patients: multicentric study. Eur J Gastroenterol Hepatol. 2016;28:e1–9.

  31. Madan SA, John F, Pitchumoni CS. Nonalcoholic fatty liver disease and mean platelet volume: a systemic review and meta-analysis. J Clin Gastroenterol. 2016;50(1):69–74.

  32. Tuzer C, Sertbas Y, Duman E, Komoglu S, Kan O, Ay S, Yigit A, Sertbas M, Okuroglu N, Ozen B, Dalbeler A, Ozdemir A. The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus. Eur J Gastroenterol Hepatol. 2021;33(9):1222–1228.

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Department, Cukurova University, 01060, Adana, Turkey

    Ümit Karaoğullarindan, Oguz Üsküdar, Emre Odabaş, Melike Saday, Anil Delik, Yüksel Gümürdülü & Sedef Kuran

  2. Endocrinology Department, Cukurova University, Adana, Turkey

    Gamze Akkuş

Authors
  1. Ümit Karaoğullarindan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oguz Üsküdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emre Odabaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Melike Saday
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gamze Akkuş
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anil Delik
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yüksel Gümürdülü
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sedef Kuran
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

UK, YG, OU, SK conceptualized the study. UK, GA and OU designed it. The material/data collection was done by UK, MS and AD. UK, AD and SK did the analysis. The literature review was done by UK, OU,YG and SK, UK, GA and SK wrote the draft. UK,OU, GA, YG, SK performed the critical review. 

Corresponding author

Correspondence to Ümit Karaoğullarindan.

Ethics declarations

Conflict of interest

UK, OU, EO, MS, GA, AD, YG and SK  declare no competing interests.

Ethics statement

The study was performed conforming to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.

Disclaimer

The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karaoğullarindan, Ü., Üsküdar, O., Odabaş, E. et al. Is mean platelet volume a simple marker of non-alcoholic fatty liver disease?. Indian J Gastroenterol 42, 219–225 (2023). https://doi.org/10.1007/s12664-022-01330-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-022-01330-8

Keywords

Search

Navigation